相关实验视频
Updated: Jun 23, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.4K
在清细胞细胞癌的类转变中,表皮细胞-介质细胞转换相关的标志物
Tanja Čugura1, Emanuela Boštjančič1, Sara Uhan1
1Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Experimental and molecular pathology
|June 14, 2024
概括
表皮-介质细胞过渡 (EMT) 是癌症的关键. 这项研究发现类细胞癌 (sRCC) 显示出分子差异,表明部分EMT,而不是完全EMT,驱动其进展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 表皮-介质细胞过渡 (EMT) 对于癌症的发展和扩散至关重要.
- 部分EMT (pEMT) 与瘤迁移有关.
- 类脏细胞癌 (sRCC) 是一种侵略性的亚型,不清楚EMT的参与.
研究的目的:
- 调查 (p) EMT在细胞癌 (RCC) 进展到sRCC中的作用.
- 为了分析EMT标志物表达在清晰细胞RCC (ccRCC) 和sRCC.
主要方法:
- 定量PCR (qPCR) 用于评估EMT标记物 (miR-200家族,miR-205,SNAI1/2,TWIST1/2,ZEB1/2,CDH1/2,VIM). 通过定量PCR检测,可以测量EMT标记物 (miR-200家族,miR-205,SNAI1/2,TWIST1/2,ZEB1/2,CDH1/2,VIM).
- 对于E-cadherin,N-cadherin,vimentin和ZEB2的免疫组织化学.
- 在ccRCC,sRCC组件 (sRCC-Ca,sRCC-Sa) 和非新形成组织之间对标记表达的比较.
主要成果:
- miR-200c在sRCC-Ca和ccRCC下调;miR-200a在sRCC-Sa和ccRCC下调. 在sRCC-Ca和ccRCC下调. 在sRCC-Sa和ccRCC下调.
- 与所有其他组相比,在sRCC-Sa中CDH1 (E-cadherin) 的调节下降.
- 在ccRCC和sRCC中降低ZEB2的调节,与非新发性脏相比.
- 在CDH1和miR-200a/b/c表达之间存在正相关性.
结论:
- 完全的EMT很可能不在sRCC中.
- 在ccRCC,sRCC-Ca和sRCC-Sa中,不同的分子概况表明了pEMT的中间状态.
- 了解这些状态可以澄清sRCC进展机制.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cadherins in Tissue Organization
3.0K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
3.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

